L-theanine may help some people report slightly better sleep, but it is not an established treatment for insomnia or another sleep disorder. Human studies are small and use different populations, products, doses, and schedules. Several trials test blends that contain other active ingredients.
This matters if you are deciding whether to buy a supplement. A positive result from one narrow trial does not show that any L-theanine product will help you fall asleep, stay asleep, get more deep sleep, or feel sharper the next morning.
What is L-theanine?
L-theanine is an amino acid found in the leaves of Camellia sinensis, the plant used to make green, black, white, and oolong tea. Supplements generally provide isolated L-theanine in capsules, tablets, powders, or gummies.
Tea and supplements are not interchangeable. An analysis of 37 commercial teas found substantial variation in both L-theanine and caffeine content, including variation within the same type of tea 1. A cup of tea therefore does not provide a controlled L-theanine dose, and its caffeine can interfere with sleep in sensitive people 2.
L-theanine is often described as calming rather than sedating. Laboratory, animal, and small human studies have explored effects on glutamate signaling, brain-wave activity, and other nervous-system pathways. These are possible mechanisms, not proof that the supplement improves sleep. An FDA evidence review concluded that the mechanisms behind L-theanine's proposed pharmacologic effects remain poorly understood 3.
What the overall sleep evidence shows
A 2025 systematic review identified 19 randomized trials with 897 participants. The meta-analysis found small improvements in subjective sleep-onset latency, daytime dysfunction, and overall subjective sleep quality 4.
These results need context:
- The effects were reported on rating scales. A standardized mean difference allows researchers to combine different questionnaires. It is not a number of minutes saved at bedtime, and it does not show how many people noticed a worthwhile change.
- The interventions were not uniform. The review included different populations and products, including combinations. Its authors specifically identified a lack of studies on pure L-theanine.
- Dose and duration remain unresolved. The review did not establish how much to take, when to take it, or how long any benefit might last.
- Subjective and objective outcomes are different. Feeling that sleep improved is valuable, but it does not establish a change in sleep stages, total sleep time, or awakenings measured by actigraphy or polysomnography.
An FDA review prepared for a 2024 Pharmacy Compounding Advisory Committee meeting reached a more conservative conclusion. Based on the evidence available at that time, it found insufficient information to support oral or sublingual L-theanine for treating sleep disorders. The agency cited small studies, short follow-up, weak or missing objective measures, other medicines or ingredients, and uncertainty about whether participants had a primary sleep disorder 3.
The two reviews asked different regulatory and research questions and used different inclusion approaches. Taken together, they support interest in further research, not a claim that L-theanine is a proven insomnia treatment.
What individual trials can and cannot tell us
A closer look at the better-known trials explains why the answer is still uncertain.
Healthy adults using L-theanine alone
One double-blind crossover trial included 30 adults without a major psychiatric disorder. Participants took 200 mg of a branded L-theanine product before sleep for four weeks and placebo for four weeks, separated by a washout period. Compared with placebo, three subscales of the Pittsburgh Sleep Quality Index improved, but the difference in the total sleep-quality score did not reach statistical significance. The study did not use objective sleep measurements 5.
The trial was small, and only a minority of the many symptom and cognitive measures differed from placebo. It was funded by Taiyo Kagaku, the company that supplied the L-theanine and placebo, and two authors were company employees. That does not invalidate the trial, but independent replication would make the result more convincing 5.
Adults with generalized anxiety disorder
A separate eight-week trial included 46 adults with generalized anxiety disorder whose symptoms had not responded fully to antidepressants. Participants continued their antidepressant and received L-theanine or placebo. The L-theanine schedule began at 450 mg per day, with some participants increasing to 900 mg per day after four weeks 6.
L-theanine did not outperform placebo on overall insomnia severity. One sleep-satisfaction item favored L-theanine, but that isolated finding does not establish an insomnia treatment. The participants had anxiety, were using antidepressants, and had an imbalance in psychotherapy use between groups, so the result also cannot be transferred directly to people with primary insomnia 6.
Boys with ADHD
A six-week trial enrolled 98 boys ages 8 to 12 with ADHD, with 93 completing the study. They received 400 mg of a branded L-theanine product each day, split between breakfast and after school, or placebo. Wrist actigraphy was recorded for five nights before and after treatment 7.
The authors reported improvement in sleep percentage and sleep efficiency, but no improvement in sleep latency or total sleep time. Parents' questionnaire responses did not track with the actigraphy findings. FDA's later appraisal also noted incomplete numerical reporting, unclear handling of missing participants, potential stimulant-medication confounding, and that none of the plotted endpoints met the authors' prespecified significance threshold of 0.01 3.
This was a specific daytime schedule in boys with ADHD, not a bedtime trial in adults with insomnia. It cannot establish a general adult dose, prove that L-theanine helps children without ADHD, or justify giving a child the supplement without clinical guidance. The study used Suntheanine, and two authors were affiliated with its manufacturer 7.
Combination products
Some positive trials do not test L-theanine by itself. For example, one four-week study in 39 adults with poor subjective sleep used a product containing 50 mg of L-theanine plus 150 mg of alpha-s1-casein tryptic hydrolysate 3.
A blend can be tested as a blend, but the result cannot show which ingredient caused a change. It also cannot establish that adding the same ingredients separately will reproduce the effect or be safe for a particular person.
Is there a recommended L-theanine dose for sleep?
No evidence-based sleep dose or timing has been established. The fact that a study used 200 mg before bed or 400 mg divided earlier in the day describes that experiment. It does not make either schedule a general recommendation.
Product instructions also vary, and combination supplements may not disclose a useful amount for each ingredient. Avoid using the upper end of a research range as a target, increasing the dose until you feel something, or adding several natural sleep aids at once. Those approaches make side effects and any benefit harder to attribute.
Do not assume L-theanine can "cancel out" late caffeine. Current sleep evidence does not establish that it restores sleep after caffeine exposure 4. Moving caffeine earlier or reducing it is the more direct experiment 2. See our guide to caffeine and sleep for a practical approach.
What safety information is available?
Short-term oral use appears to be tolerated by many adults in clinical studies, but the safety record is less complete than promotional language suggests. In FDA's review, studies in healthy adults lasted from one day to six weeks. Only six of 19 studies explicitly said they observed no adverse events; 13 did not report or discuss them. Studies in people with medical conditions reported gastrointestinal symptoms, headache, sedation, vivid dreams, fatigue, and other events, but other medicines and health conditions often made it impossible to identify the cause 3.
One child in the ADHD sleep trial developed a facial tic four days after starting L-theanine and left the study. The child had a prior history of tics, so the event does not prove that L-theanine caused it 3.
Stop taking the product and contact a clinician if you develop a concerning symptom. Do not drive, cycle in traffic, or use machinery if you feel sleepy, dizzy, slowed, or otherwise impaired. Trouble breathing, facial or throat swelling, fainting, severe confusion, or another rapidly worsening reaction requires urgent medical care 8.
Who should get clinical advice first?
Direct interaction and long-term safety data are limited. Discuss the exact product with a clinician or pharmacist before using it if you:
- take blood-pressure medicine, have low blood pressure, or have unexplained fainting or dizziness
- take a sedating medicine, use alcohol near bedtime, or already use another sleep product
- take several medicines or supplements, especially when changes are hard to separate
- are pregnant, trying to become pregnant, or breastfeeding
- are considering L-theanine for a child or teenager
- have a diagnosed sleep, psychiatric, neurologic, kidney, liver, or cardiovascular condition
These are reasons to check for individual risks, not proof of a specific interaction. FDA's 2024 review found no developmental or reproductive toxicity studies and limited pediatric evidence. FDA also advises consumers that supplements can interact with medicines and that problems are more likely when products are combined 38.
What FDA status does and does not mean
FDA's GRAS Notice No. 209 covers specified uses of L-theanine as an ingredient in certain foods, up to 250 mg per serving. The notice records that FDA had no questions about the notifier's conclusion under those intended food-use conditions 9.
It is not FDA approval of L-theanine as a sleep aid. It does not establish that a supplement treats insomnia, that any dose is safe for everyone, or that every product contains what its label claims. FDA does not approve dietary supplements for safety and effectiveness before they are sold 8.
If you decide to buy a supplement, prefer a single-ingredient product that states the amount per serving. Independent quality seals can help verify identity, label accuracy, and contamination testing, but they do not prove that the product is safe or effective. The National Institutes of Health lists NSF, USP, and ConsumerLab among organizations that perform independent quality testing 10.
Verify a certification in the issuing organization's directory rather than relying only on a logo in a product listing.
A practical way to decide
Start with the sleep problem, not the supplement.
- Define what you want to change. Difficulty falling asleep, repeated awakenings, an early wake time, restless legs, snoring, and daytime sleepiness can have different causes and need different responses.
- Remove an obvious disruptor first. Late caffeine, alcohol near bedtime, an irregular schedule, pain, noise, or a medicine side effect may be a more direct target.
- Check the exact product. Look for L-theanine as the only active ingredient, a stated amount per serving, and verifiable independent quality testing. Avoid a proprietary sleep blend if you want to know whether L-theanine helps.
- Change one thing at a time. Follow the label and any clinician guidance rather than inventing a dose or stacking products. Record bedtime, estimated time to fall asleep, awakenings, wake time, next-day sleepiness, and side effects.
- Reassess instead of continuing automatically. Stop if you feel worse or impaired. If there is no clear, useful change, adding more or taking it indefinitely is not supported by the evidence.
L-theanine should not delay assessment of persistent insomnia, loud snoring or breathing pauses, uncomfortable urges to move the legs, severe daytime sleepiness, or a sudden change in sleep. For chronic insomnia in adults, the American Academy of Sleep Medicine strongly recommends cognitive behavioral therapy for insomnia, or CBT-I. This treatment addresses the thoughts and behaviors that keep insomnia going and has a much stronger evidence base than L-theanine 11.
